Statistics

Total Visits

Views
CABAZITAXEL PLUS PREDNISONE IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (mCRPC) PREVIOUSLY TREATED WITH DOCETAXEL: ANALYSIS BY AGE GROUP27

Select a period of time:

Number of views in the range

Views
CABAZITAXEL PLUS PREDNISONE IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (mCRPC) PREVIOUSLY TREATED WITH DOCETAXEL: ANALYSIS BY AGE GROUP14

Views

Views
January 20250
February 20252
March 20257
April 20252
May 20251
June 20252
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore7
United States4
Brazil2
Spain1
 

Top cities views

Views
Arapiraca1
Council Bluffs1
Los Angeles1
Rio de Janeiro1